Atlas Trials

A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)

Clinical trial NCT04941404 · TERMINATED

Trial details

NCT number
NCT04941404
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Glucocorticoid-Refractory aGVHD
Start date
2022-06-10
Primary completion
2023-07-10
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.